3

PRIMARY DOCUMENT

Company: BIOCRYST PHARMACEUTICALS INC
Filed: February 28, 2011
Period of Report: February 18, 2011
Accession Number: 0001127602-11-007871

View Document ↗ View on SEC.gov ↗